ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
Clinical trial NCT04480502 · UNKNOWN
Trial details
- NCT number
- NCT04480502
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2024-10-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.